Introduced in the Fall of 2003, the NIH Clinical Trial Planning Grant Program was developed to provide support for the development of Phase III clinical trials. This program supports the establishment of the research team, the development of tools for data management and oversight of the research, the definition of recruitment strategies, and the finalization of the protocol and other essential elements of the study included in a manual of operations/procedures. The Clinical Trial Planning Grant is not designed for the collection of preliminary data or the conduct of pilot studies to support the rationale for a clinical trial.
Some of the non-participating ICs may solicit R34 applications using specific Funding Opportunity Announcements (FOAs) in order to meet specific programmatic needs. In some cases those announcements may specify different application characteristics, review criteria, and receipt dates. All such announcements will be published in the NIH Guide for Grants and Contracts at http://grants.nih.gov/grants/guide/index.html. The FOA for investigator-initiated R34 applications can be found at PA-06-363 and articulates the policies and procedures that apply to this program.
NIH Institute and Center Contacts and Scientific Research Areas of Interest |
NIH Institute/Center |
Scientific/Research
Contact |
Financial or Grants Management
Contact |
| NIH Institutes, Centers, and Offices that Accept NIH Clinical Trial Planning Grant (R34) Applications Under Parent Funding Opportunity Announcement (FOA), PA-06-363, Released April 19, 2006 |
National Institute on Aging (NIA) |
Ms. Joanna Badinelli
Phone: 301-435-3046
FAX: 301-480-1066
Email: BadinelJ@mail.nih.gov |
Linda Whipp
Phone: 301-496-1472
FAX: 301-402-3672
Email: whippL@mail.nih.gov |
| The National Institute on Aging (NIA) will accept investigator-initiated R34 applications for all program areas supported by the Institute. |
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
|
Margaret E. Mattson, Ph.D.
Phone: 301-443-0638
FAX: 301-443-8774
Email: mmattson@mail.nih.gov |
Judy Fox
Phone: 301-443-4704
FAX: 301-443-3891
Email: jfox@mail.nih.gov
|
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) will accept R34 applications in response to a Request for Applications (RFA), or when NIAAA has specifically agreed to accept an application after discussion between the potential applicant and program staff. |
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
|
Madeline Turkeltaub, RN,PhD,CRNP,FAAN
Deputy Director, Extramural Program
NIAMS
6701 Democracy Blvd. Suite 800
Bethesda, MD 20892
Phone: 301-451-5888
FAX: 301-480-4543
Email: mturkeltaub@mail.nih.gov
|
Melinda B. Nelson
Phone: 301-594-3535
FAX: 301-480-5450
Email: mn23z@nih.gov |
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will accept R34 applications for all program areas supported by the Institute.
For information regarding specific scientific programs and contacts, see http://www.niams.nih.gov/rtac/index.htm. |
National Institute of Child Health and Human Development (NICHD)
|
Eugene G. Hayunga, Ph.D.
Phone: 301-435-6856
FAX: 301-480-2400
Email: ehayunga@mail.nih.gov |
John Chris Robey
Phone: 301-435-6996
FAX: 301-451-5510
Email: robeyj@mail.nih.gov |
The National Institute of Child Health and Human Development (NICHD) accepts R34 applications for planning of Phase III clinical trials in all program areas supported by the Institute. |
National Institute on Deafness and Other Communication Disorders (NIDCD) |
Ling Chin, MD, MPH
Phone: 301-435-4085
FAX: 301-402-6251
Email: lchin@nidcd.nih.gov
For a list of scientific staff, also see Staff Contacts. |
Christopher Myers
Phone: 301-435-0713
FAX: 301-402-1758
Email: myersc@mail.nih.gov |
The National Institute on Deafness and Other Communication Disorders (NIDCD) uses the R34 mechanism to support planning of all investigator-initiated clinical trials when NIDCD has specifically agreed to accept an application after discussion between the potential applicant and program staff. |
National Institute on Drug Abuse (NIDA) |
Teresa Levitin, Ph.D.
Phone: 301-443-2755
FAX: 301-443-0538
Email: TL25u@nih.gov |
Diana Haikalis
Phone: 301-443-6710
FAX: 301-594-6849
Email: dhaikali@nida.nih.gov
|
The National Institute on Drug Abuse (NIDA) The National Institute on Drug Abuse (NIDA) will accept investigator-initiated R34 applications for all program areas supported by the Institute. |
National Institute of Neurological Disorders and Stroke (NINDS)
|
Scott Janis, Ph.D.
Phone: 301-496-9135
FAX: 301-480-1080
Email: sj151t@nih.gov |
James E. Washington, M.Ed.
Phone: 301-496-7449
FAX: 301-451-5635
Email: washingj@ninds.nih.gov |
The National Institute of Neurological Disorders and Stroke (NINDS) will accept investigator-initiated R34 applications for all program areas supported by the Institute. See NINDS Overview |
National Eye Institute (NEI) |
Dr. Donald F. Everett
Email: dfe@nei.nih.gov
Dr. Natalie Kurinij
Email: kurinij@nei.nih.gov
Dr. Paivi H. Miskala
Email: miskala@nei.nih.gov
Dr. Maryann Redford
Email: maryann.redford@nei.nih.gov
Phone for all: 301-451-2020
FAX for all: 301-402-0528 |
William Darby
Phone: 301-435-8179
FAX: 301-496-9997
Email: darbyw@mail.nih.gov |
The National Eye Institute (NEI) accepts investigator-initiated R34 applications for all program areas supported by the Institute. The Planning Grant is used to support the development of a detailed MOP and may include preliminary studies to refine study procedures or to document recruitment potential. Applicants may request direct costs up to $150,000 per year for up to two years of support. |
Office of Rare Diseases (ORD) |
Dr. Giovanna Spinella
Phone: (301-496-0139,
FAX:
Email: SpinellG@mail.nih.gov |
|
| Office of Dietary Supplements (ODS) |
Dr. Rebecca Costello
Phone: 301-435-3605
FAX: 301 480-1845
Email: CostellB@od.nih.gov |
|
| The Office of Dietary Supplements (ODS) is a potential source of co-funding to support R34 applications for planning of clinical trials relevant to dietary supplements. |
| NIH Institutes and Centers that Accept NIH Clinical Trial Planning Grant (R34) Applications Under Their Specific FOA(s) ONLY |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Sanford Garfield, Ph.D (for behavioral research)
Phone: 301-594-8803
FAX: 301-480-3503
E-mail: sg50o@nih.gov
Barbara Linder, M.D., Ph.D. (for pediatric medical research)
Phone: 301-594-0021
FAX: 301-480-3503
E-mail: bl99n@nih.gov
Myrlene Staten, M.D. (for adult medical research)
Phone: 301-402-7886
FAX: 301-480-3503
E-mail: ms808k@nih.gov
Robert Kuczmarski (for obesity research)
Phone: 301-451-8354
FAX: 301-480-8300
E-mail: rk191r@nih.gov |
|
See PAR-06-358 |
| National Institute of Mental Health (NIMH) |
Joel Sherrill, Ph.D.
Division of Services and Intervention Research
Phone: 301-443-2477
FAX: 301-594-6784
Email: jsherril@mail.nih.gov
Dianne Rausch, Ph.D.
Division of AIDS and Health and Behavior Research
Phone: 301-443-6100
FAX: 301-443-9719
Email: drausch@mail.nih.gov |
Rebecca Claycamp, M.S., CRA
Phone: 301-443-2811
FAX: 301-443-6885
Email: rclaycam@mail.nih.gov |
| See PAR-06-248 |
